38 results
DEF 14A
NTBL
Notable Labs Ltd
16 Feb 24
Definitive proxy
9:00am
Officer shall not exceed 95% of such Executive Officer’s total compensation package for such year.
Base Salary
The Company will seek to establish … compensation package offered to an Executive Officer of the Company with compensation packages for persons serving in similar positions
PRE 14A
NTBL
Notable Labs Ltd
5 Feb 24
Preliminary proxy
5:00pm
on a linear basis) of each Executive Officer shall not exceed 95% of such Executive Officer’s total compensation package for such year.
Base Salary … the level of the overall compensation package offered to an Executive Officer of the Company with compensation packages for persons serving
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
candidates;
the clinical indication(s) for which Volasertib and Fosciclopirox and Notable’s other drug candidates are approved;
drug label and package insert
S-4/A
yup06 qyz5xmg
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
389noiex40
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.9
iah w9bpkrxyat6
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-99.2
nq090kb8p 36b7364
2 Jun 22
Notice of Annual General Meeting of Shareholders
5:00pm
424B5
bxijgyv s27mxg
11 Feb 22
Prospectus supplement for primary offering
5:28pm
424B8
0ob799rpzi
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
6wb nhadyn
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
ufaa 1egfzdr28
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
opj0v
9 Apr 21
Prospectus supplement for primary offering
12:00am
424B5
vq9n6tlaz 3g1
15 Jan 21
Prospectus supplement for primary offering
7:00am